MarketPeel
Pricing
…
President, Head of R&D
Briggs Morrison
Fri, Apr 1, 2022
Apr 1
exercised or converted securities in SNDX
70,545 shares @ $10.90
Increased holdings by +395.50%
Net across this filing: -63.10% (-30,500 shares)
Option Exercise
Sale tied to a same-time option exercise
SNDXSyndax Pharmaceuticals Inc
HealthcareBiotechnology
1D0.00%
1W-0.56%
1M-5.57%
3M-1.26%
6M—
1Y—

Recent insider activity at SNDX

Jul 8Michael A. MetzgerSold$784.78kJun 12Nicholas A.j. BotwoodSold$566.60kJun 11Nicholas A.j. BotwoodSold$617.04kJun 1Keith A. GoldanSold$22.35kJun 1Michael A. MetzgerSold$130.02kFeb 9Michael A. MetzgerSold$360.82kFeb 9Keith A. GoldanSold$71.71kFeb 6Michael A. MetzgerSold$152.84k
Full SNDX profile →Briggs Morrison’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback